Source: Annual Congress 2005 - New modalities and application in lung and airway imaging
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. A. Jones, H. M. Branley, R. J. Shiner, A. R. Boobis (London, United Kingdom). Influence of acute smoking on pulmonary inflammatory cell activity measured by positron emission tomography (PET) in asymptomatic cigarette smokers. Eur Respir J 2005; 26: Suppl. 49, 3030

Member's Comments

No comment yet.

Related content which might interest you: Imaging the inflammatory activity of sarcoidosis Source: Eur Respir J 2013; 41: 743-751 Year: 2013 Measurement of airway inflammation in smokers by means of positron emission tomography Source: Annual Congress 2012 - Functional imaging of the lung parenchyma, tumours and circulation Year: 2012 In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma Source: Eur Respir J 2003; 21: 567-573 Year: 2003 The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245 Year: 2004 Quantitative 18F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPD Source: ERJ Open Res, 7 (3) 00699-2020; 10.1183/23120541.00699-2020 Year: 2021 Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001 Rebuttal Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 (18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Positron emission tomography (PET) and computed tomography (CT) in the assessment of the mediastinum for patients with presumed or established lung cancer Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008 Advances in chest imagery Source: Annual Congress 2006 - Clinical year in review Year: 2006 Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration Source: Eur Respir J 2009; 33: 201-212 Year: 2009 Positron emission tomography (PET) using 18F-fluorodeoxyglucose (18FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 The place of non-invasive techniques (CT - PET - CT) Source: Annual Congress 2007 - Mediastinal staging for NSCLC Year: 2007 New imaging techniques in the treatment guidelines for lung cancer Source: Eur Respir J 2002; 19: 71S-83S Year: 2002 Single photon emission computed tomography (SPECT) in the non-invasive diagnosis cardiac sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 356s Year: 2006 18F-fluorodeoxyglucose (18FDG) PET pulmonary imaging in COPD Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015 Imaging in lung cancer: positron emission tomography scan Source: Eur Respir J 2002; 19: 49S-60S Year: 2002 Single photon emission tomography combined with computer tomography (SPECT/CT) for assessment of COPD patients for lung volume reduction surgery Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery Year: 2008 Imaging can replace mediastinoscopy: PRO Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 Assessing nodules detected in lung cancer screening: the value of positron emission tomography Source: Eur Respir J 2015; 45: 314-316 Year: 2015